These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32061912)

  • 1. Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways.
    Qi J; Tan Y; Fan D; Pan W; Yu J; Xu W; Wu J; Zhang M
    J Ethnopharmacol; 2020 May; 253():112660. PubMed ID: 32061912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy.
    Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B
    J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of mechanisms of Chinese medicinal formula Si-Miao-Yong-an decoction protects against cardiac hypertrophy and fibrosis in isoprenaline-induced heart failure.
    Zhao Y; Jiang Y; Chen Y; Zhang F; Zhang X; Zhu L; Yao X
    J Ethnopharmacol; 2020 Feb; 248():112050. PubMed ID: 31265887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of dioscin against isoproterenol-induced cardiac hypertrophy via adjusting PKCε/ERK-mediated oxidative stress.
    Li R; Qi Y; Yuan Q; Xu L; Gao M; Xu Y; Han X; Yin L; Liu C
    Eur J Pharmacol; 2021 Sep; 907():174277. PubMed ID: 34171391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways.
    Song R; Xiong C; Bai J; Bai Z; Liu W
    Curr Mol Pharmacol; 2023 Oct; ():. PubMed ID: 38258596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway.
    Mao HP; Wang XY; Gao YH; Chang YX; Chen L; Niu ZC; Ai JQ; Gao XM
    J Ethnopharmacol; 2016 Jun; 186():20-29. PubMed ID: 26970569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
    Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Chinese Medicine Xinmailong's protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes.
    Qi J; Yu J; Tan Y; Chen R; Xu W; Chen Y; Lu J; Liu Q; Wu J; Gu W; Zhang M
    Sci Rep; 2017 Feb; 7():42843. PubMed ID: 28205629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial].
    Fu L; Mao ZX; Wang J; Zhang J; Zheng TR; Wang SL
    Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):509-13. PubMed ID: 19583930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca
    Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L
    Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kuanxiong aerosol inhibits apoptosis and attenuates isoproterenol-induced myocardial injury through the mitogen-activated protein kinase pathway.
    Lu Y; Yang M; Peng M; Xie L; Shen A; Lin S; Huang B; Chu J; Peng J
    J Ethnopharmacol; 2021 Apr; 269():113757. PubMed ID: 33359915
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Cao YY; Li K; Li Y; Tian XT; Ba HX; Wang A; Li XH
    Pharm Biol; 2020 Dec; 58(1):176-183. PubMed ID: 33826488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aliskiren and carvedilol on expression of Ca(2+)/calmodulin-dependent protein kinase II δ-subunit isoforms in cardiac hypertrophy rat model.
    Bin-Dayel AF; Abdel Baky NA; Fadda LM; Mohammad RA; Al-Mohanna F
    Toxicol Mech Methods; 2016 Feb; 26(2):122-31. PubMed ID: 26982530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
    Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy.
    Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G
    J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.
    Li H; Mao Y; Zhang Q; Han Q; Man Z; Zhang J; Wang X; Hu R; Zhang X; Irwin DM; Niu G; Tan H
    J Ethnopharmacol; 2016 Nov; 192():459-470. PubMed ID: 27586823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CaMKII phosphorylation site Thr1604 in the Ca
    Li J; Wang S; Zhang J; Liu Y; Zheng X; Ding F; Sun X; Zhao M; Hao L
    Channels (Austin); 2020 Dec; 14(1):151-162. PubMed ID: 32290730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway.
    Wu JB; Zhou Y; Liang CL; Zhang XJ; Lai JM; Ye SF; Ouyang H; Lin J; Zhou JY
    Chin J Integr Med; 2017 Oct; 23(10):770-778. PubMed ID: 27048408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.